Translating the OHTS results into clinical practice

Journal of Glaucoma

Volumn 11, Issue 5, 2002, Pages 375-377

  Cioffi, George A ^a   Liebmann, Jeffrey M ^a  

^a DEVERS EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; CLINICAL PRACTICE; EDITORIAL; EVIDENCE BASED MEDICINE; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE ABNORMALITY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0036787609     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00061198-200210000-00001     Document Type: Editorial

References (6)

1. Kass MA, Heuer DK, Higginbotham EJ, et al., for the Ocular Hypertension Study Group. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open angle glaucoma. Arch Ophthalmol 2002;120:701-13.
2. Gordon MO, Beiser JA, Brandt JD, et al., for the Ocular Hypertension Study Group. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open angle glaucoma. Arch Ophthalmol 2002;120:714-20.
3. Gordon MO, Kass MA. The Ocular Hypertension Treatment Study: design and baseline description of the participants. Arch Ophthalmol 1999;117:573-83.
4. Johnson CA, Keltner JL, Cello KE, et al. Baseline visual field characteristics in the Ocular Hypertension Treatment Study. Ophthalmology 2002;109:432-7.
5. Johnson CA, Sample, Trick GL. Short Wavelength Automated Perimetry (SWAP) in the Ocular Hypertensive Treatment Study (OHTS). Invest Ophthalmol Vis Sci 2002;(ARVO Suppl):86.
6. Brandt JD, Beiser JA, Kass MA, Gordon MO. Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS). Ophthalmology 2001;108:1779-88.